A randomized, double-blind, placebo--controlled, cross-over design with forskolin eye drops (1.0% suspension) revealed a highly significant maximum reduction in 25% in IOP in 6 h after instillation of forskolin eye drops. 12 Another study conducted in 1986, concurs that two repeated instillations of 1% forskolin lowered the IOP significantly and decreased the aqueous flow by 13%, while a single instillation had no appreciable effect on
← all excerpts
Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study.
1
—
—